As a member of the Center for Vector-Borne Infectious Diseases (CVID) at Colorado State University, the Foy laboratory focuses on the interactions of vectors with their hosts and with vector pathogens. The goal is to link research employing molecular, proteomic and genomic techniques to practical applications for controlling arthropod-borne diseases. A main research component in the Foy lab is to interrupt the intense transmission of malaria and arboviruses by targeting the vector through their bloodmeals using drugs that attack vector physiology and that inhibit pathogen development or using anti-vector immunity driven by vaccination. The Foy lab is also developing mosquitoes and other vectors as biosurveillance tools, studying unique aspects of arbovirus transmission and arbovirus survival in vectors, and studying poorly understood mosquito pathogens for their prospects to become vector-borne disease control tools.
People
news and updates view all
Brian Foy and Tony Schountz from the Center of Vector-Borne Infectious Diseases discussed the science behind animal-to-human transmission of infectious diseases and how COVID-19 has played out thus far.
An international team led by CSU Professor Brian Foy found that they were able to reduce cases of malaria in children in several villages in Burkina Faso by 20 percent, using a drug called ivermectin.
Brian Foy explains the scientific aims of a recent international study in Burkina Faso to reduce malaria transmission using a drug called ivermectin.
contact information
Office: Center for Vector-Borne Infectious Diseases room 168
(970) 491-3470
brian.foy@colostate.edu